Correlation Between Zenith Capital and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Zenith Capital and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenith Capital and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenith Capital Corp and Cue Biopharma, you can compare the effects of market volatilities on Zenith Capital and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenith Capital with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenith Capital and Cue Biopharma.
Diversification Opportunities for Zenith Capital and Cue Biopharma
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Zenith and Cue is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Zenith Capital Corp and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Zenith Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenith Capital Corp are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Zenith Capital i.e., Zenith Capital and Cue Biopharma go up and down completely randomly.
Pair Corralation between Zenith Capital and Cue Biopharma
Assuming the 90 days horizon Zenith Capital Corp is expected to generate 14.4 times more return on investment than Cue Biopharma. However, Zenith Capital is 14.4 times more volatile than Cue Biopharma. It trades about 0.1 of its potential returns per unit of risk. Cue Biopharma is currently generating about 0.0 per unit of risk. If you would invest 18.00 in Zenith Capital Corp on August 29, 2024 and sell it today you would lose (7.00) from holding Zenith Capital Corp or give up 38.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zenith Capital Corp vs. Cue Biopharma
Performance |
| Timeline |
| Zenith Capital Corp |
| Cue Biopharma |
Zenith Capital and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zenith Capital and Cue Biopharma
The main advantage of trading using opposite Zenith Capital and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenith Capital position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.The idea behind Zenith Capital Corp and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |